KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder for investors with losses over $100,000 in Kyverna Therapeutics, Inc. to file lead plaintiff applications by February 7, 2025, in a class action lawsuit related to the company's IPO.
January 29, 2025 | 4:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its IPO, with a lead plaintiff deadline of February 7, 2025. This could impact the company's stock price negatively in the short term.
The class action lawsuit against Kyverna Therapeutics is directly related to its IPO, which could lead to negative investor sentiment and potential stock price decline. The deadline for lead plaintiff applications is approaching, which may increase attention and volatility around the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100